V. Foos

The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making

Andrew Palmer, Stéphane Roze, William J. Valentine et al. · Current Medical Research and Opinion · 2004 · 519 citations

Validation of the IMS CORE Diabetes Model

Phil McEwan, V. Foos, James L. Palmer et al. · Value in Health · 2014 · 229 citations

Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States

V. Foos, N. Varol, Bradley Curtis et al. · Journal of Medical Economics · 2015 · 118 citations · Full text

Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge

Andrew Palmer, Lei Si, Michelle Tew et al. · Value in Health · 2018 · 75 citations · Full text

Obesity, Diabetes Management, Engineering +10

Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes

Joshua Ray, Kristina S. Boye, Nicole Yurgin et al. · Current Medical Research and Opinion · 2007 · 55 citations